Testing effectiveness (Phase 2)Ended earlyNCT02625922
What this trial is testing
Study of the Effect of Serelaxin on High-sensitivity Cardiac Troponin I (Hs-cTnI) Release in Patients With Chronic Heart Failure
Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 26